Gilead Sciences | Der Umsatz

Sales Veränderung Datum
AbbVie USD 12.31B 1.99B 2024-03
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
ALKERMES USD 350.4M 27.08M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
Amgen USD 7.45B 746M 2024-03
Biogen USD 2.29B 96.3M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Bristol-Myers Squibb USD 11.9B 423M 2024-03
Eli Lilly USD 8.77B 583.4M 2024-03
Gilead Sciences USD 7.12B 64M 2023-12
GlaxoSmithKline GBP 7.36B 692M 2024-03
Glaxosmithkline GBP 8.05B 95M 2023-12
Incyte USD 880.89M 132.45M 2024-03
J&J USD 21.38B 15M 2024-03
Merck USD 15.8B 1.17B 2024-03
Moderna USD 167B 164.19B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.9B 651M 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Sanofi EUR 10.92B 1.05B 2023-12
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
United Therapeutics USD 677.7M 63M 2024-03
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Gilead Sciences Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2024.